MoneyWorks4Me

Amanta Healthcare - Quaterly Results

11 Feb 2026 Evaluate
The company witnessed a 9.84% growth in the revenue at Rs. 744.87 millions for the quarter ended December 2025 as compared to Rs. 678.15 millions during the year-ago period.Modest increase of 8.08% in the Net Profit was reported from. 42.81 millions to Rs. 46.27  millions.Operating profit for the quarter ended December 2025 rose to 160.37 millions as compared to 159.32 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202512 202412 % Var
Sales 744.87 678.15 9.84 744.87 678.15 9.84 744.87 678.15 9.84
Other Income 6.77 8.70 -22.18 6.77 8.70 -22.18 6.77 8.70 -22.18
PBIDT 160.37 159.32 0.66 160.37 159.32 0.66 160.37 159.32 0.66
Interest 50.61 58.98 -14.19 50.61 58.98 -14.19 50.61 58.98 -14.19
PBDT 109.76 100.34 9.39 109.76 100.34 9.39 109.76 100.34 9.39
Depreciation 46.74 45.05 3.75 46.74 45.05 3.75 46.74 45.05 3.75
PBT 63.02 55.29 13.98 63.02 55.29 13.98 63.02 55.29 13.98
TAX 16.75 12.48 34.21 16.75 12.48 34.21 16.75 12.48 34.21
Deferred Tax -3.66 1.27 -388.19 -3.66 1.27 -388.19 -3.66 1.27 -388.19
PAT 46.27 42.81 8.08 46.27 42.81 8.08 46.27 42.81 8.08
Equity 343.36 282.70 21.46 343.36 282.70 21.46 343.36 282.70 21.46
PBIDTM(%) 21.53 23.49 -8.36 21.53 23.49 -8.36 21.53 23.49 -8.36
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..